Severe CAV MRI in Heart Transplant Recipient

NCT02777255 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-05-19

No results posted yet for this study

Summary

Hypothesis: CAV is associated with fibrotic changes on cardiac MRI, altered levels of pathogenetically-related biomarkers, and specific RNA expression changes in the blood

Conditions

  • Cardiac Allograft Vasculopathy

Sponsors & Collaborators

Principal Investigators

  • Monica M Colvin-Adams, MD.,MS · University of Minnesota

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2014-05-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02777255 on ClinicalTrials.gov